Search results for: Multi-Indication Medicines
Filter search results
Supporting the Era of Green Pharmaceuticals in the UK
1 November 2022
…to be taken now by governments, health systems, medicines regulators and companies globally to secure the era of green pharmaceuticals. The core analysis for this report was undertaken before the…
Mike Paulden – 2022 Prize Finalist
18 January 2023
…medicines and other health technologies. His research on time preference and discounting has contributed towards guidelines used for economic evaluations in Canada and elsewhere. He has a particular interest in…
Claud Theakston
26 January 2023
…and processes across countries, as well as the broader value of medicines to society and how health economics can help us respond to and prepare for challenges and demographic changes….
The Economics of Antibiotics – Part 2: Value Assessment within the NICE-NHS AMR Pilot
12 October 2022
…in England for decades to assess the value of medicines and decide whether or not the NHS will pay for them [1]. The first problem with the reimbursement of antibiotics…
Siva Anandaciva
3 February 2023
…in the Department of Health working on medicines policy and urgent and emergency care. Siva is a member of the Office of Health Economics policy committee and chairs the National…
Matthias Hofer
5 April 2023
…competitiveness of the UK pharmaceutical sectors. He has also worked at the European Medicines Agency (EMA) and UK Research and Innovation (UKRI), where he was involved in the incentivisation, regulation,…
Claudio Jommi
19 April 2023
…Assessment). His research activity is focused on Pharmaceutical Economics, Policy and Management, Health Technology Assessment, and Market Access for Medicines. He has had his work published in many international and…
Real-World Evidence: Current Best Practice for Reimbursement Decision-Making
15 May 2023
…decisions around patient access to medicines is appropriate, transparent, and methodologically sound. We urge stakeholders internationally to work together to find the best solutions to advance our understanding and use…
Setting the Right Discount Rate for HTA in the Slovak Republic
21 May 2023
Health interventions such as new medicines produce costs and health-related effects not only in the year they are introduced but in all future years until they are discontinued. People generally…